IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

NICHETTI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.591
NA - Nord America 2.045
AS - Asia 2.025
SA - Sud America 180
AF - Africa 33
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.982
DE - Germania 1.276
CN - Cina 651
SG - Singapore 499
IT - Italia 377
HK - Hong Kong 223
GB - Regno Unito 219
SE - Svezia 176
VN - Vietnam 171
BD - Bangladesh 144
BR - Brasile 134
RU - Federazione Russa 121
FR - Francia 95
IN - India 94
NL - Olanda 76
JP - Giappone 54
IE - Irlanda 51
TW - Taiwan 49
FI - Finlandia 48
CA - Canada 40
BE - Belgio 26
UA - Ucraina 23
KR - Corea 21
PL - Polonia 20
TR - Turchia 20
ID - Indonesia 18
AR - Argentina 17
AT - Austria 17
CI - Costa d'Avorio 15
ES - Italia 15
MX - Messico 15
PK - Pakistan 12
IQ - Iraq 11
PH - Filippine 11
AU - Australia 8
DK - Danimarca 8
SA - Arabia Saudita 8
IR - Iran 7
CH - Svizzera 6
HU - Ungheria 6
PT - Portogallo 6
UZ - Uzbekistan 6
VE - Venezuela 6
CL - Cile 5
PY - Paraguay 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
JO - Giordania 4
MA - Marocco 4
AP - ???statistics.table.value.countryCode.AP??? 3
BO - Bolivia 3
CO - Colombia 3
GR - Grecia 3
JM - Giamaica 3
KE - Kenya 3
RO - Romania 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
MY - Malesia 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
UY - Uruguay 2
BT - Bhutan 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GF - Guiana Francese 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
MV - Maldive 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.886
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.173
Ashburn 258
Singapore 253
Hong Kong 183
Chandler 174
San Jose 156
Southend 153
Dallas 112
Beijing 105
Milan 104
Fairfield 80
Council Bluffs 72
Hefei 62
Los Angeles 55
Hanoi 53
Dublin 50
Houston 50
Woodbridge 50
Ann Arbor 49
New York 48
Wilmington 46
Ho Chi Minh City 44
Princeton 44
Seattle 42
Dearborn 38
Redwood City 35
Santa Clara 35
Boardman 34
Taipei 34
Munich 33
Cambridge 32
Lauterbourg 31
Guangzhou 30
Helsinki 30
Moscow 28
Shanghai 28
Bengaluru 27
Buffalo 27
Nanjing 22
Rome 21
Brussels 20
Tokyo 19
Des Moines 18
Shenyang 18
Phoenix 17
Wuhan 16
Abidjan 15
Jakarta 15
Bühl 14
Columbus 14
Jinan 14
The Dalles 14
Toronto 14
Amsterdam 13
Cangzhou 13
Naples 13
Seoul 13
Turku 13
Zhengzhou 13
Central District 12
Chicago 12
Da Nang 12
London 12
Mumbai 12
São Paulo 12
Hangzhou 11
Nanchang 11
Bologna 10
Fuzhou 10
Nuremberg 10
Tianjin 10
Warsaw 10
Islamabad 9
Istanbul 9
Haiphong 8
Hyderabad 8
Berlin 7
Fremont 7
Genoa 7
Grafing 7
Hebei 7
Little Rock 7
Montreal 7
Turin 7
Vienna 7
Atlanta 6
Baghdad 6
Changsha 6
Haikou 6
Hải Dương 6
Manchester 6
Mexico City 6
San Diego 6
Chennai 5
Erlangen 5
Iwasakichō 5
Lappeenranta 5
Miami 5
New Delhi 5
Ottawa 5
Totale 4.511
Salva come PNG Salva come JPEG
Nome #
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis 629
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 517
Clinical implications for pro-GRP in small cell lung cancer. A single center experience 435
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 320
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 319
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study 280
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? 261
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 252
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 227
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer : A Literature-Based Systematic Review and Meta-Analysis 225
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 219
Genomic markers of resistance to targeted treatments in gastric cancer : potential new treatment strategies 217
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 211
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 204
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy : the MA.NI.LA. multicenter, randomized, controlled, phase II trial 198
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs 192
Treatment of Advanced Merkel Cell Carcinoma : Current Therapeutic Options and Novel Immunotherapy Approaches 188
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 186
Diet and supplements in cancer prevention and treatment : clinical evidences and future perspectives 182
The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma : a Comprehensive Review 173
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component 169
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 167
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 164
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 162
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report 162
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program 157
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 149
Bilateral parotid gland metastases from gastric signet-ring cell carcinoma 131
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer 108
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications 105
Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer 104
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis 102
null 3
Totale 7.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022473 49 35 24 35 24 31 14 31 43 87 25 75
2022/2023592 68 80 52 56 46 111 10 58 54 7 42 8
2023/20241.124 9 29 28 31 68 33 184 151 94 152 174 171
2024/20251.393 145 153 127 137 63 47 68 105 73 118 132 225
2025/20262.337 257 184 222 162 158 131 375 58 235 162 316 77
Totale 7.118